Wrap up interview: Evolving BRS techniques to the acute myocardial infarction patient


Will the recent FDA approval of a first generation BRS change the way we practice? Will this increase the “momentum” of the development and clinical use of BRS? What are the challenges today with this technology and, as we build on first generation devices, as we expand indications…what does the present, and the future hold for us...

Find out as we join A. Abizaid and I. Meredith discussing the very hot topic of bioresorbable scaffolds from the Elixir DESolve to AMITY!